NASDAQ: IRIX
Iridex Corp Stock Ownership - Who owns Iridex?

Insider buying vs selling

Have Iridex Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick MercerPresident and CEO2025-06-304,243$0.88
$3.74kSell
Patrick MercerPresident and CEO2025-06-13250$0.96
$240.00Buy
Patrick MercerPresident and CEO2025-06-1333,370$2.00
$66.74kBuy
William M. MooreDirector2025-06-1320,000$0.97
$19.38kBuy
Romeo R. DizonChief Financial Officer2025-06-1322,500$2.00
$45.00kBuy
Romeo R. DizonChief Financial Officer2025-06-1322,500$2.00
$45.00kBuy
Romeo R. DizonChief Financial Officer2025-06-1322,500$0.94
$21.15kBuy
Patrick MercerPresident and CEO2025-06-1333,370$0.94
$31.37kBuy
William M. MooreDirector2025-06-1220,000$0.98
$19.50kBuy
William M. MooreDirector2025-06-1110,000$0.96
$9.63kBuy

1 of 6

IRIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRIX insiders and whales buy or sell their stock.

IRIX Shareholders

What type of owners hold Iridex Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blueline Catalyst Fund IX LP15.24%2,559,122$2.74MInsider
Blueline Capital Partners II LP14.94%2,508,100$2.68MInsider
Blueline Partners LLC 114.79%2,483,815$2.66MInsider
Blueline Partners LLC14.68%2,465,222$2.64MInsider
Scott Shuda10.42%1,750,059$1.87MInsider
Topcon America Corp9.64%1,618,122$1.73MInsider
Associates Paragon Associates Ii Joint Venture Paragon7.86%1,320,000$1.41MInsider
Acuta Capital Fund LP6.89%1,157,011$1.24MInsider
Blueline Capital Partners LP6.78%1,138,862$1.22MInsider
Paragon Associates Paragon Associates II Joint Venture5.96%1,000,000$1.07MInstitution

1 of 3

IRIX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRIX13.99%86.01%Net BuyingNet Buying
ALUR14.24%85.76%Net BuyingNet Buying
ADGM53.31%46.69%
NXL2.31%20.42%Net Buying
NSYS2.84%97.16%Net BuyingNet Buying

Iridex Stock Ownership FAQ

Who owns Iridex?

Iridex (NASDAQ: IRIX) is owned by 18.74% institutional shareholders, 115.24% Iridex insiders, and 0.00% retail investors. Blueline Catalyst Fund IX LP is the largest individual Iridex shareholder, owning 2.56M shares representing 15.24% of the company. Blueline Catalyst Fund IX LP's Iridex shares are currently valued at $3.30M.

If you're new to stock investing, here's how to buy Iridex stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.